Evidence map›Paper›PMID 40263528›Full record

ArticleMolecular psychiatry2025

Integrative analysis of miRNA expression profiles reveals distinct and common molecular mechanisms underlying broad diagnostic groups of severe mental disorders.

Pierre Solomon, Lalit Kaurani, Monika Budde, Jean-Baptiste Guiné, Dennis Manfred Krüger, Kevin Riquin, Tonatiuh Pena, Susanne Burkhardt, Cynthia Fourgeux, Kristina Adorjan and 32 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Pierre Solomon *Nantes Université, CHU-Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID 0000-0001-7187-2664
Lalit Kaurani *Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.ORCID 0000-0002-2304-6111
Monika Budde *Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Jean-Baptiste GuinéNantes Université, CHU-Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
Dennis Manfred KrügerDepartment for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.ORCID 0000-0003-1950-9547
Kevin RiquinNantes Université, CHU-Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID 0000-0003-1774-0286
Tonatiuh PenaDepartment for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.ORCID 0000-0002-9329-8912
Susanne BurkhardtDepartment for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Cynthia FourgeuxNantes Université, CHU-Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID 0000-0002-3330-7530
Kristina AdorjanInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Maria HeilbronnerInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Janos L KalmanInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Mojtaba Oraki KohshourInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-1357-2636
Sergi PapiolInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-9366-8728
Daniela Reich-ErkelenzInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Sabrina K SchauppInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Eva C SchulteInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-3105-5672
Fanny SennerInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Thomas VoglInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.
Ion-George AnghelescuDepartment of Psychiatry and Psychotherapy, Mental Health Institute Berlin, Berlin, Germany.
Volker AroltInstitute for Translational Psychiatry, University of Münster, Münster, Germany.ORCID 0000-0002-2445-9778
Bernhardt T BauneDepartment of Psychiatry, University of Münster, Münster, Germany.
Udo DannlowskiInstitute for Translational Psychiatry, University of Münster, Münster, Germany.ORCID 0000-0002-0623-3759
Detlef E DietrichAMEOS Clinical Center Hildesheim, Hildesheim, Germany.
Andreas J FallgatterDepartment of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), University of Tübingen, Tübingen, Germany.
Christian FiggeKarl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg, Germany.
Georg JuckelDepartment of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.
Carsten KonradDepartment of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg, Germany.
Jens ReimerDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0007-5406-5319
Eva Z ReininghausDivision of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.ORCID 0000-0001-5964-4087
Max SchmaußClinic for Psychiatry, Psychotherapy and Psychosomatics, Augsburg University, Medical Faculty, Bezirkskrankenhaus Augsburg, Augsburg, Germany.
Carsten SpitzerDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Rostock, Rostock, Germany.
Jens WiltfangDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0003-1492-5330
Jörg ZimmermannPsychiatrieverbund Oldenburger Land GMBH, Karl-Jaspers-Klinik, Bad Zwischenahn, Germany.
Anna-Lena SchützResearch Group for Genome Dynamics in Brain Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany.
Farahnaz SananbenesiResearch Group for Genome Dynamics in Brain Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany.
Anne SauvagetNantes Université, CHU Nantes, Movement - Interactions - Performance, MIP, UR 4334, Nantes, France.
Peter FalkaiMax Planck Institute of Psychiatry, Munich, Germany.ORCID 0000-0002-0284-2290
Thomas G SchulzeInstitute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-6624-2975
André Fischer *Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Urs Heilbronner *Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-7135-762X
Jeremie Poschmann *Nantes Université, CHU-Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France. jeremie.poschmann@univ-nantes.fr.ORCID 0000-0002-9613-5297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro RNAs (miRNAs) play a crucial role as regulators of various biological processes and have been implicated in the pathogenesis of mental disorders such as schizophrenia and bipolar disorders. In this study, we investigate the expression patterns of miRNAs in the PsyCourse Study (n = 1786), contrasting three broad diagnostic groups: Psychotic (Schizophrenia-spectrum disorders), Affective (Bipolar Disorder I, II and recurrent Depression), and neurotypic healthy individuals. Through comprehensive analyses, including differential miRNA expression, miRNA transcriptome-wide association study (TWAS), and predictive modelling, we identified multiple miRNAs unique to Psychotic and Affective groups as well as shared by both. Furthermore, we performed integrative analysis to identify the target genes of the dysregulated miRNAs and elucidate their potential roles in psychosis. Our findings reveal significant alterations of multiple miRNAs such as miR-584-3p and miR-99b-5p across the studied diagnostic groups, highlighting their role as molecular correlates. Additionally, the miRNA TWAS analysis discovered previously known and novel genetically dysregulated miRNAs confirming the relevance in the etiology of the diagnostic groups. Importantly, novel factors and putative molecular mechanisms underlying these groups were uncovered through the integration of miRNA-target gene interactions. This comprehensive investigation provides valuable insights into the molecular underpinnings of severe mental disorders, shedding light on the complex regulatory networks involving miRNAs.

Indexed as

Mental DisordersMicroRNAsAdultBipolar DisorderFemaleGene Expression ProfilingGene Regulatory NetworksGenome-Wide Association StudyHumansMaleMiddle AgedPsychotic DisordersSchizophreniaTranscriptomeMicroRNAs

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.